Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

DOSE EXPANDS ITS SCIENCE-BACKED APPROACH TO THE CORE SYSTEMS QUIETLY POWERING THE BODY WITH NEW BLOOD PRESSURE LIQUID SUPPLEMENT

Dose logo

News provided by

Dose

Sep 28, 2026, 12:00 ET

Share this article

Share toX

Share this article

Share toX

The new doctor-formulated, clinically studied liquid supplement combines plant-powered ingredients with finished-formula clinical validation to support healthy blood pressure, blood flow and vascular function*

NEW YORK, Sept. 28, 2026 /PRNewswire/ -- Dose today announced the launch of Dose for Blood Pressure™, a doctor-formulated daily liquid supplement designed to support healthy blood pressure, including blood flow, vascular function and circulation. Dose for Blood Pressure is the first liquid supplement [product on the market] to show a statistically significant positive impact on both diastolic and systolic blood pressure in its own double blind, randomized, placebo-controlled clinical study. The launch marks a significant next chapter for Dose, expanding the brand's science-backed approach beyond liver health and cholesterol to another important, and often silent, marker of long-term health.*

Continue Reading
Dose Blood Pressure Clinical Study Findings Chart
Dose Blood Pressure Clinical Study Findings Chart

Dose is a clinically-backed supplement brand built on the belief that lasting health begins by supporting the body's core systems and the key health markers tied to them, including liver health, cholesterol and now blood pressure. Through liquid formulations that combine recognizable, plant-powered ingredients backed by science, Dose helps consumers take a proactive approach to long-term health with measurable results they can see in their lab work and feel in everyday life.*

"From day one, our vision has been to help people take more control of their long-term health by supporting the core systems quietly powering their bodies," said Vasu Goyal, Founder of Dose. "Blood pressure was a natural next step because it's one of the most important, and often misunderstood, health markers. Too many people assume they'll feel when something is changing, when in reality blood pressure can change quietly over time. We saw an opportunity to bring the same rigorous scientific approach that defined our liver and cholesterol formulas to another critical area of long-term health."

Blood pressure was a natural next step in Dose's expansion into the core systems and health markers that can meaningfully affect long-term health without producing obvious signs. Like liver health and cholesterol, changes in blood pressure can happen quietly, making it an important area for proactive, consistent support. As Dose's first new product innovation since 2022, Dose for Blood Pressure reflects the brand's highly intentional approach to product development, including 18 months spent refining the formulation through over 100 iterations, and putting it through extensive scientific and clinical testing before bringing it to market.

Rather than relying on a single ingredient or pathway, Dose engineered a multi-mechanism formulation combining a proprietary Veldt Grape & Turmeric Blend with science backed CoQ10, grapeseed and folate. Together, the ingredients provide complementary support across healthy blood flow and vascular function, cellular and heart health, antioxidant support and cardiovascular wellness. *

Dose also tackled one of the category's key scientific challenges: delivering a clinically backed botanical blend in a stable, absorbable and great-tasting liquid. Using its proprietary formulation and absorption platform, Dose developed the formula in its signature liquid format and went beyond ingredient-level research to clinically evaluate the finished Dose for Blood Pressure formulation, providing clinical validation of the formula as a whole, not just its individual ingredients.

In a randomized, double-blind, placebo-controlled clinical study based on 1-2 servings, Dose for Blood Pressure showed a statistically significant and meaningful positive impact in both systolic and diastolic blood pressure.*^ 

Study findings included:

  • 91% of participants showed a positive impact in systolic blood pressure.1†*
  • 74% of participants showed a positive impact in diastolic blood pressure.1†*

1When taken twice daily

^ Based on a 4-week randomized, double-blind, placebo-controlled clinical study in healthy adults without hypertension per JNC-7/WHO criteria. Percent improvement is based on at least 2 mmHg positive change in systolic or diastolic blood pressure.

† Based on a 4-week randomized, double-blind, placebo-controlled clinical study in healthy participants as defined by JNC-7/WHO criteria.

Results from Dose for Blood Pressure clinical study complement established approaches like DASH diet and regular exercise.††

††Results are from separate studies and may not be directly comparable.

"Supporting healthy blood pressure isn't about targeting a single ingredient or pathway, it's about supporting an interconnected biological system," said Dr. Jiah Pearson-Leary, Director of Science at Dose. "That's why we designed Dose for Blood Pressure as a multi-mechanism formulation, combining clinically studied ingredients to support healthy blood flow, vascular function and circulation. Just as importantly, we clinically validated the finished formulation, not just the individual ingredients, because consumers deserve confidence in the product they're actually taking every day. *

The launch of Dose for Blood Pressure marks the next phase in the evolution of the Dose brand, expanding it from a brand primarily known for liver health into a broader platform supporting the core systems quietly powering the body. Anchored by the brand idea "Healthy Happens Quietly," the evolution reflects a simple truth: consumers can't necessarily feel their liver filtering, cholesterol changing or blood pressure rising, yet these unseen changes can have a meaningful impact on long-term health. Through an expanded portfolio, greater emphasis on clinical research and an evolved brand experience, Dose is helping consumers take proactive daily action before their bodies ask them to.

Dose for Blood Pressure joins the brand's existing portfolio supporting liver health and cholesterol, establishing Dose as one cohesive platform helping consumers care for the core systems quietly powering their bodies.

Beginning August 31, Dose for Blood Pressure will be available exclusively on dosedaily.co in two sizes: a 16 fl oz bottle (8 servings), available as a three-pack for $90 or six-pack for $160, and a 2 fl oz bottle (1 serving), available individually for $4.99 or as a 24-pack for $99. The formula is vegan, kosher, gluten-free and non-GMO,

To learn more about Dose for Blood Pressure and explore Dose's full portfolio, visit dosedaily.co.

About Dose
Dose is a clinically backed supplement brand creating doctor-formulated liquid supplements that help consumers take a proactive approach to long-term health by supporting the body's core systems. Combining recognizable, plant-powered ingredients with clinical research, each formula is thoughtfully designed with ingredient blends to deliver measurable results consumers can see in their lab work and feel through consistent daily use. *

The Dose portfolio includes solutions for liver health, cholesterol and blood pressure, all delivered in a convenient, great-tasting liquid format that simplifies daily supplementation without compromising efficacy. By helping consumers care for the body's core health systems, Dose is making proactive wellness approachable, effective and easy to fit in your daily routine.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Media Contact: [email protected]

SOURCE Dose

21%

more press release views with 
Request a Demo

Modal title

Also from this source

DOSE PARTNERS WITH JUICE PRESS TO DEBUT LIMITED-TIME SMOOTHIE, BRINGING CLINICALLY-BACKED WELLNESS TO EVERYDAY RITUALS

DOSE PARTNERS WITH JUICE PRESS TO DEBUT LIMITED-TIME SMOOTHIE, BRINGING CLINICALLY-BACKED WELLNESS TO EVERYDAY RITUALS

Today, Dose, the clinically-backed supplement brand redefining daily wellness through liquid formulations designed to support the body's core health...

More Releases From This Source

Explore

Retail

Retail

Fitness/Wellness

Fitness/Wellness

Supplementary Medicine

Supplementary Medicine

Medical Pharmaceuticals

Medical Pharmaceuticals

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content

About

  • About PR Newswire
  • About Cision
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2026 Cision US Inc.